Informations:
Erreur:
ID
30946
Description
Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00819195
Lien
https://clinicaltrials.gov/show/NCT00819195
Mots-clés
Versions (1)
- 05/07/2018 05/07/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
5 juillet 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Multiple Sclerosis NCT00819195
Eligibility Multiple Sclerosis NCT00819195
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT00819195
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Multiple Sclerosis, Relapsing-Remitting
Item
relapsing-remitting (rr) ms patients (mcdonald criteria)
boolean
C0751967 (UMLS CUI [1])
Age
Item
ages 18-55
boolean
C0001779 (UMLS CUI [1])
Gender
Item
males and females
boolean
C0079399 (UMLS CUI [1])
EDSS
Item
edss score ≤5
boolean
C0451246 (UMLS CUI [1])
Copaxone Therapy naive
Item
no prior treatment with copaxone
boolean
C0528175 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0919936 (UMLS CUI [1,2])
Adrenal Cortex Hormones | Interferon beta-1a | Interferon beta-1b | Washout Period Required
Item
prior treatment with corticosteroids or interferon-beta (-1a or -1b) is acceptable, provided there is a washout period of at least one month
boolean
C0001617 (UMLS CUI [1])
C0254119 (UMLS CUI [2])
C0244713 (UMLS CUI [3])
C1710661 (UMLS CUI [4,1])
C1514873 (UMLS CUI [4,2])
C0254119 (UMLS CUI [2])
C0244713 (UMLS CUI [3])
C1710661 (UMLS CUI [4,1])
C1514873 (UMLS CUI [4,2])
Tysabri | Novantrone | Cyclophosphamide
Item
treatment with tysabri, novantrone or cyclophosphamide
boolean
C1529600 (UMLS CUI [1])
C0282248 (UMLS CUI [2])
C0010583 (UMLS CUI [3])
C0282248 (UMLS CUI [2])
C0010583 (UMLS CUI [3])
Immunomodulation | Imuran | MYCOPHENOLATE | Methotrexate
Item
treatment with other immunomodulatory therapies (e.g. imuran, mycophenolate or methotrexate)
boolean
C1963758 (UMLS CUI [1])
C0699279 (UMLS CUI [2])
C0883242 (UMLS CUI [3])
C0025677 (UMLS CUI [4])
C0699279 (UMLS CUI [2])
C0883242 (UMLS CUI [3])
C0025677 (UMLS CUI [4])
Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Secondary Progressive
Item
primary-progressive (pp) and secondary-progressive (sp) multiple sclerosis
boolean
C0751964 (UMLS CUI [1])
C0751965 (UMLS CUI [2])
C0751965 (UMLS CUI [2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])